In Part 1 we ended with the question: So what (or who) is driving this Liberal government to follow the Harper governments path in championing trade deals that are not in the interest of the country and why is this government evading its responsibilities to improve health of Canadians?
We know the TPP was negotiated with asymmetric secrecy, away from the public and behind closed doors. Sham ‘consultations’ aside (i.e. waiting for the US congress to make a decision and wanting to present the auspices of public input), this deal has been driven by industry. Specifically the major force behind this deal is the pharmaceutical industry, or ‘big pharma’ as it is colloquially known. While media attention, especially in Canada, tend to focus on the ‘big oil’s’ role in influencing government policies, behind the scenes the pharmaceutical industry and their lobby make all others look like bit players.